Cara Therapeutics, Inc. /
Tvardi Therapeutics, Inc.
Cara Therapeutics and Tvardi Therapeutics complete merger
What happened
Cara Therapeutics, Inc. completed its merger with Tvardi Therapeutics, Inc. on April 15, 2025. Tvardi became a wholly owned subsidiary of Cara.
Tvardi is a clinical-stage biopharmaceutical company developing oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases.
The source
Everything on this page comes from the source below.
Cara Therapeutics and Tvardi Therapeutics complete merger
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly